[Reevaluation of the surgical indications for non-small cell lung cancer based on the results of postoperative treatment].
Patients who undergo complete surgical resection for pathological stage I-IIIa non-small cell lung cancer (NSCLC) are candidates for postoperative chemo- and/or radiotherapy. The indications for surgical resection are not a problematic issue, regardless of the results of postoperative therapy. So far there have been no definitively positive results in randomized phase III trials comparing postoperative adjuvant therapy with no further therapy. Therefore clinical trials should be conducted to determine the most appropriate postoperative regimen in NSCLC.
Ichinose
Y
Y
Department of Chest Surgery, National Kyushu Cancer Center, Fukuoka, Japan.
D002289:Carcinoma, Non-Small-Cell Lung / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery*; D018714:Radiotherapy, Adjuvant